CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
DXST
Decent Holding Inc.
There isn't enough reported data to score DXST yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
DXST Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Strong |
DXST's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
DXST PE Valuation
DXST has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
DXST Forward outlook
There aren't enough analyst estimates for DXST to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the stronger earnings trend. Trailing diluted EPS is up 31% for CAT versus DXST down 115%.
DXST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.75 | -115% |
| Q3 2025 | $2.26 | +33% |
| Q2 2025 | $3.91 | +$4.01 |
| Q1 2025 | $4.62 | +58% |
| Q4 2024 | $4.98 | +10% |
| Q3 2024 | $1.70 | -62% |
| Q2 2024 | -$0.10 | -102% |
| Q1 2024 | $2.92 | +56% |
DXST has swung to a loss: it lost $0.75 per share over the past year, after a profit the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
DXST has the stronger quarterly revenue trend. Revenue is up 17% for CAT versus up 238% for DXST.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
DXST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.6M | +238% |
| Q4 2025 | $7.5M | -20% |
| Q3 2025 | $3.7M | -20% |
| Q2 2025 | $5.5M | +147% |
| Q4 2024 | $9.3M | +342% |
| Q3 2024 | $4.7M | +342% |
| Q2 2024 | $2.2M | -39% |
| Q1 2024 | $1.1M | -70% |
DXST's revenue is growing: $19M last quarter, up 238% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4.7% | +3.8 points |
| Q1 2026 | -4.7% | N/A |
| Q4 2025 | 4.4% | -23 points |
| Q3 2025 | 4.4% | -23 points |
| Q2 2025 | -8.5% | -6.5 points |
| Q4 2024 | 27% | +30 points |
| Q3 2024 | 27% | +30 points |
| Q2 2024 | -2% | -32 points |
DXST's operating margin was −4.7% last quarter, up 3.8 points from the same quarter a year ago, near the bottom of its range since 2022.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with DXST at down 1,867%.
DXST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.7M | -$5.1M |
| Q1 2026 | -$2.9M | -$2.1M |
| Q4 2025 | -$2.8M | -$2.8M |
| Q3 2025 | -$1.4M | -$1.4M |
| Q2 2025 | -$613.1K | -$218K |
| Q1 2025 | -$780.3K | -$582.7K |
| Q4 2024 | -$45.3K | -111% |
| Q3 2024 | -$22.7K | -107% |
DXST has burned cash in most quarters: −$13M over the past year, against −$1M the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
DXST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
| Q4 2023 | -0.5x | Net Cash |
| Q2 2023 | -0.4x | Net Cash |
| Q4 2022 | -0.0x | Very low |
DXST has more cash than debt.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DXST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.9 | Neutral |
| Stochastic | 0.2 | Oversold |
DXST's weekly RSI is 32 (neutral) and its Stochastic is 0 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
DXST PE vs Industrials Sector
DXST has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has stronger trend alignment. CAT is above 2 of 5 weekly averages versus DXST above 0 of 3.
DXST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.46 | 48% below |
| 20 week MA | $2.08 | 63% below |
| 50 week MA | $9.10 | 92% below |
DXST is in a downtrend: it's below all three of its weekly moving averages, and 92% below its 50-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over DXST on returns for 2026, with the stronger performance.
DXST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $51.0 | $32.3 | -37% |
| 2026 YTD | $32.3 | $0.76 | -98% |
DXST has finished every year since 2025 lower, and it's down 98% so far in 2026.